Approval · Notice of Compliance 16427 · 2014
SIMBRINZA: Notice of Compliance 16427
Issued December 11, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16427
- Date
- December 11, 2014
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Elevated intraocular pressure therapy (topical carbonic anhydrase inhibitor and topical alpha-2 agonist agent)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIMBRINZA | 02435411 | Marketed |
Medicinal ingredients
- BRIMONIDINE TARTRATE 0.2 PER
- BRINZOLAMIDE 1 PER